Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience Academic Article Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Coronary Artery Disease
  • Drug-Eluting Stents
  • Heart Transplantation

abstract

  • Because cardiogenic shock occurred most often after admission and with recurrent ischemia and reinfarction, recognizing signs of incipient shock may improve outcome. Fewer patients treated with rt-PA developed shock, yet those developing shock had the same high mortality rate as those presenting with shock, regardless of treatment. Only angioplasty was associated with a significantly lower mortality rate.

publication date

  • January 1995

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/0735-1097(95)00215-P

PubMed ID

  • 7642857

Additional Document Info

start page

  • 668

end page

  • 74

volume

  • 26

number

  • 3